Document is current
Any future updates will be listed below
-
Authors
Tse, Brandon
Nisenbaum, Rosane
Floros, Georgina
Jiwajee, Aziz
Teitel, Jerome
Sholzberg, Michelle
- License Information
-
More Information
Article History
Accepted: 21 November 2022
First Online: 22 December 2022
Declarations
:
: MS has received unrestricted research funding from Takeda and Octapharma. She has previously received honoraria for advisory boards from Takeda, Octapharma, Bayer and NovoNordisk. JT has been a paid consultant and and Advisory Board member for Bayer, Takeda, Novo Nordisk, and Pfizer. He has received research support from Pfizer, Bayer, and Takeda. BT, RN, GF, and AJ have no conflicts to disclose.
